Ignite Creation Date:
2025-12-24 @ 9:48 PM
Ignite Modification Date:
2026-02-06 @ 3:11 AM
Study NCT ID:
NCT03783832
Status:
UNKNOWN
Last Update Posted:
2018-12-21
First Post:
2018-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Follow up of Diabetic Macular Edema Treated by Aflibercept (Eylea®) With OCT-Angiography
Sponsor:
Aquitania Opthalmologica
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2017-A03478-45
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None